Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes

NCT04893148 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Glucose, High Blood

Interventions

DRUG: IGlarLixi
DRUG: Dulaglutide

Sponsor

Chungbuk National University Hospital